Mitral stenosis of rheumatic origin with dyspnea, palpitations and referred bronchial asthma. Case presentation
Keywords:
valve disease, mitral stenosis, rheumatic fever, cardiac pseudoasma, intracavitary thrombus, pulmonary hypertension, clinical methodAbstract
Mitral stenosis is a valvular heart disease characterized by abnormal narrowing of the mitral valve orifice. Physiopathologically, increased force to overcome the stenotic valve can enlarge the left atrium. This enlargement favors the appearance of atrial fibrillation and the formation of thrombi. The retrograde repercussion towards the pulmonary circulation brings alterations, symptoms and signs of the respiratory system. A 59-year-old female patient is presented with a diagnosis of bronchial asthma of 30 years of evolution, who comes for worsening of the dyspnoea and palpitations of more than a month of evolution, through physical examination and the verification of results with imaging studies. As part of the clinical method, a severe mitral stenosis of rheumatic etiology with the presence of intra-atrial thrombus was diagnosed. The patient received emergency treatment, progressed satisfactorily on admission and was referred to the tertiary level on an outpatient basis for better study and surgical treatment. The case is presented due to the importance of the prevention of rheumatic diseases and the need to take into account and act accordingly, the possibility of respiratory manifestations as evidence of cardiovascular disorders, including valve disorders and mitral stenosis in particular.Downloads
Download data is not yet available.
References
1. Chambers JB, Bridgewater B: Epidemiology of valvular heart disease. In Otto CM, Bonow RO, editors: Valvular Heart Disease: A Companion to Braunwald's Heart Disease, 4th ed., Philadelphia, 2013, Saunders, pp 1-13. [Citado 19 nov 2019]
2. Essop MR, NkomoVT: Rheumatic and nonrheumatic valvular heart disease: Epidemiology, management, and prevention in Africa, Circulation 112:3584,2005. Byrne JG et al: Repair versus replacement of mitral valve for treating severe ischemic mitral regurgitation. Coron Artery Dis 11:31, 2017 [PMID: 10715803] [Citado 19 nov 2019]
3. López Nistal L M, Pérez Rodríguez N, Alonso Alomá I, Cabrera Aedo R, Torres, Vidal R M, Sosa Marín M R, et al Anuario Estadístico de Salud, La Habana 2017 p. 71 [Citado 19 nov 2019]
4. Lung B, Vahanian A: Rheumatic mitral valve disease. In Otto CM, Bonow RO, editors: Valvular Heart Disease: A Companion to Braunwald's Heart Disease, 4th ed., Philadelphia, 2013, Saunders, pp 255-277. [Citado 19 nov 2019]
5. Fitzgerald, J Mark (mayo de 2015). Global Strategy for Asthma Management and Prevention. [Citado 19 nov 2019].
6. Llanio Navarro R, Perdomo González G. Propedéutica Clínica y Semiología Médica. Tomo 1. La Habana; 2003 p. 515-16 [Citado 19 nov 2019]
7. Cruz Hernández Jeddú, Hernández García Pilar, Abraham Marcel Enrique, Dueñas Gobel Nancy, Salvato Dueñas Alena. Importancia del Método Clínico. Rev Cubana Salud Pública [internet]. 2012 SEP [Citado 2019 nov 19]; 38(3): 422-437 Disponible en: http//scielo.sld.cu/scielo.php?script=sci_arttext&pid=s0864-4662012000300009&Ing=es
8. Marón BJ, Araujo CG, Thompson PD, et al: Recommendations for reparticipation screening and the assessment of cardiovascular disease in master athletes: An advisory for healthcare professionals from the working groups of the World Heart Federation, the International Federation of Sports Medicine, and the American Heart Association Committee on Exercise, Cardiac Rehabilitation, and Prevention, Circulation 103:327,2016. [Citado 19 nov 2019]
2. Essop MR, NkomoVT: Rheumatic and nonrheumatic valvular heart disease: Epidemiology, management, and prevention in Africa, Circulation 112:3584,2005. Byrne JG et al: Repair versus replacement of mitral valve for treating severe ischemic mitral regurgitation. Coron Artery Dis 11:31, 2017 [PMID: 10715803] [Citado 19 nov 2019]
3. López Nistal L M, Pérez Rodríguez N, Alonso Alomá I, Cabrera Aedo R, Torres, Vidal R M, Sosa Marín M R, et al Anuario Estadístico de Salud, La Habana 2017 p. 71 [Citado 19 nov 2019]
4. Lung B, Vahanian A: Rheumatic mitral valve disease. In Otto CM, Bonow RO, editors: Valvular Heart Disease: A Companion to Braunwald's Heart Disease, 4th ed., Philadelphia, 2013, Saunders, pp 255-277. [Citado 19 nov 2019]
5. Fitzgerald, J Mark (mayo de 2015). Global Strategy for Asthma Management and Prevention. [Citado 19 nov 2019].
6. Llanio Navarro R, Perdomo González G. Propedéutica Clínica y Semiología Médica. Tomo 1. La Habana; 2003 p. 515-16 [Citado 19 nov 2019]
7. Cruz Hernández Jeddú, Hernández García Pilar, Abraham Marcel Enrique, Dueñas Gobel Nancy, Salvato Dueñas Alena. Importancia del Método Clínico. Rev Cubana Salud Pública [internet]. 2012 SEP [Citado 2019 nov 19]; 38(3): 422-437 Disponible en: http//scielo.sld.cu/scielo.php?script=sci_arttext&pid=s0864-4662012000300009&Ing=es
8. Marón BJ, Araujo CG, Thompson PD, et al: Recommendations for reparticipation screening and the assessment of cardiovascular disease in master athletes: An advisory for healthcare professionals from the working groups of the World Heart Federation, the International Federation of Sports Medicine, and the American Heart Association Committee on Exercise, Cardiac Rehabilitation, and Prevention, Circulation 103:327,2016. [Citado 19 nov 2019]
Published
2021-05-19
How to Cite
1.
Miguel-Hernández CA, Rodríguez-Castro A, Pérez-Fleites DA. Mitral stenosis of rheumatic origin with dyspnea, palpitations and referred bronchial asthma. Case presentation. MedEst [Internet]. 2021 May 19 [cited 2024 Nov. 21];1(1):e08. Available from: https://revmedest.sld.cu/index.php/medest/article/view/8
Issue
Section
CASE PRESENTATION
License
Those authors who have publications with this journal accept the following terms: The authors will retain their copyright and guarantee the journal the right of first publication of their work, which will be simultaneously subject to the Recognition License. Creative Commons that allows third parties to share the work as long as its author and its first publication in this magazine are indicated. Authors may adopt other non-exclusive license agreements for the distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a monographic volume) as long as the initial publication in this journal is indicated. Authors are allowed and recommended to disseminate their work through the Internet (e.g.: in institutional telematic archives or on your website) before and during the submission process, which can produce interesting exchanges and increase citations of the published work.
